G0S2 and breast cancer: The sensitivity of G0/G1 transition gene 2 (G0S2) breast cancer cells to tamoxifen was relatively increased, which makes G0S2 an antitumor breast cancer target and biomarker of recurrence and therapeutic response [28, 29].